Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 301–400 of 1,001
Rupprecht, R., Wetzel, C. H., Dorostkar, M. M., Herms, J. W., Albert, N. L., Schwarzbach, J. V., Schumacher, M., & Neumann, I. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01561-3 · Cited by 73
Perucca, E., White, H. S., & Bialer, M. (2023) · CNS Drugs · doi:10.1007/s40263-023-01025-4 · Cited by 72
Editing of Neurotransmitter Receptor and Ion Channel RNAs in the Nervous System
Hood, J. L., & Emeson, R. B. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_157 · Cited by 72
Jensen, H. S., Nichol, K. E., Lee, D., & Ebert, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088456 · Cited by 72
Darrah, S. D., Miller, M. A., Ren, D., Hoh, N. Z., Scanlon, J. M., Conley, Y. P., & Wagner, A. K. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.07.006 · Cited by 72
Russell, M. G. N., Carling, R. W., Atack, J. R., Bromidge, F. A., Cook, S. M., Hunt, P. A., Isted, C., Lucas, M., McKernan, R. M., Mitchinson, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040883v · Cited by 72
Pharmacological Treatment of Insomnia
Schweitzer, P. K., & Feren, S. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-41400-3_7 · Cited by 71
Memory Effects of Benzodiazepines: Memory Stages and Types Versus Binding‐Site Subtypes
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., & Bokonjić, D. R. (2005) · Neural Plasticity · doi:10.1155/np.2005.289 · Cited by 71
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
Meldrum, B. S. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00066-9 · Cited by 71
General anesthesia mediated by effects on ion channels
Zhou, C., Liu, J., & Chen, X. (2012) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v1.i3.80 · Cited by 70
Principles of agonist recognition in Cys-loop receptors
Lynagh, T., & Pless, S. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00160 · Cited by 70
Varagić, Z., Ramerstorfer, J., Huang, S., Rallapalli, S., Sarto‐Jackson, I., Cook, J. M., Sieghart, W., & Ernst, M. C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12153 · Cited by 69
ANXIETY IN MAJOR DEPRESSION AND CEREBROSPINAL FLUID FREE GAMMA-AMINOBUTYRIC ACID
Mann, J. J., Oquendo, M. A., Watson, K. T., Boldrini, M., Malone, K. M., Ellis, S. P., Sullivan, G. M., Cooper, T. B., Xie, S., & Currier, D. (2014) · Depression and Anxiety · doi:10.1002/da.22278 · Cited by 69
Ortinski, P. I., Turner, J. R., Barberis, A., Motamedi, G. K., Yasuda, R. P., Wolfe, B. B., Kellar, K. J., & Vicini, S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2610-06.2006 · Cited by 69
Jensen, M. S., Hoerrner, R. S., Li, W., Nelson, D. P., Javadi, G. J., Dormer, P. G., Cai, D., & Larsen, R. D. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050741o · Cited by 69
Rodgers, R. J., Davies, B., & Shore, R. F. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.10406.x · Cited by 69
Kaufmann, W. A., Humpel, C., Alheid, G. F., & Marksteiner, J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04082-9 · Cited by 69
Christian, E. P., Snyder, D. H., Song, W., Gurley, D. A., Smolka, J., Maier, D. L., Ding, M., Gharahdaghi, F., Liu, X. F., Chopra, M., et al. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00539.2013 · Cited by 68
Lorenzo, L.-É., Godin, A. G., Wang, F., St-Louis, M., Carbonetto, S., Wiseman, P. W., Ribeiro-da-Silva, A., & Koninck, Y. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0159-14.2014 · Cited by 68
Gallos, G., Yim, P. D., Chang, S., Zhang, Y., Xu, D., Cook, J. M., Gerthoffer, W. T., & Emala, C. W. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00131.2011 · Cited by 68
Costa, E., Auta, J., Grayson, D. R., Matsumoto, K., Pappas, G. D., Zhang, X., & Guidotti, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00199-5 · Cited by 68
In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic
Foster, A. C., Pelleymounter, M. A., Cullen, M. J., Lewis, D., Joppa, M. A., Chen, T., Bozigian, H. P., Gross, R. S., & Gogas, K. R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063487 · Cited by 68
Atack, Jr., Hallett, D., Tye, S., Wafford, K., Ryan, C., Sanabria-Bohórquez, S., Eng, W.-S., Gibson, R., Burns, H., Dawson, G., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109354928 · Cited by 63
Ator, N. A., Atack, J. R., Hargreaves, R. J., Burns, H. D., & Dawson, G. R. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158303 · Cited by 66
Cheng, T., Wallace, D. M., Ponteri, B. B., & Tuli, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164307 · Cited by 66
Sleep EEG changes after zolpidem in mice
Kopp, C., Rudolph, U., & Tobler, I. (2004) · NeuroReport · doi:10.1097/00001756-200410050-00031 · Cited by 66
Self-citationAnxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure
Fischer, B. D., Licata, S. C., Edwankar, R. V., Wang, Z.-J., Huang, S., He, X., Yu, J., Zhou, H., Johnson, E. M., Cook, J. M., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.011 · Cited by 66
Vislay, R. L., Martin, B. S., Olmos-Serrano, J. L., Kratovac, S., Nelson, D. L., Corbin, J. G., & Huntsman, M. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2764-12.2013 · Cited by 59
Dixon, C. I., Rosahl, T. W., & Stephens, D. N. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.015 · Cited by 66
Savić, M. M., Milinković, M. M., Rallapalli, S., Clayton, T., Joksimovic, S. M., Linn, M., & Cook, J. M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000108 · Cited by 66
Boldrini, M., Butt, T. H., Santiago, A. N., Tamir, H., Dwork, A. J., Rosoklija, G. B., Arango, V., Hen, R., & Mann, J. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000844 · Cited by 59
Nickolls, S. A., Gurrell, R., van Amerongen, G., Kammonen, J., Cao, L., Brown, A. R., Stead, C., Mead, A. N., Watson, C. A., Hsu, C. C., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14119 · Cited by 66
Keynote review: Allosterism in membrane receptors
Gao, Z., & Jacobson, K. A. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03689-5 · Cited by 66
Allosteric modulation of ligand-gated ion channels
Hogg, R. C., Buisson, B., & Bertrand, D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.06.010 · Cited by 66
Atack, J. R., Wafford, K. A., Street, L. O. N. D. O. N. G., Dawson, G. R., Tye, S. J., Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., Lepeleire, I. D., de Hoon, J., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109354927 · Cited by 65
Sotiriou, E., Papatheodoropoulos, C., & Angelatou, F. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20670 · Cited by 65
Atack, J. R. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2007.00034.x · Cited by 52
Resolving differences in GABAA receptor mutant mouse studies
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · Nature Neuroscience · doi:10.1038/80553 · Cited by 65
Self-citationIs there a way to curb benzodiazepine addiction?
Lalive, A. L., Rudolph, U., Lüscher, C., & Tan, K. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13277 · Cited by 64
Self-citationLayer-Specific Noradrenergic Modulation of Inhibition in Cortical Layer II/III
Salgado, H., García‐Oscos, F., Patel, A. A., Martinolich, L., Nichols, J., Dinh, L., Roychowdhury, S., Tseng, K.-Y., & Atzori, M. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq081 · Cited by 64
Fritsch, B., Qashu, F. M., Figueiredo, T. H., Aroniadou‐Anderjaska, V., Rogawski, M. A., & Braga, M. F. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.034 · Cited by 64
A new meaning for “Gin & Tonic”: tonic inhibition as the target for ethanol action in the brain
Módy, I., Glykys, J. C., & Wei, W. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.03.009 · Cited by 64
Takahashi, A., Yap, J. J., Bohager, D. Z., Faccidomo, S., Clayton, T., Cook, J. M., & Miczek, K. A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1437-8 · Cited by 54
Molecular mechanisms of general anesthesia
Son, Y. H. (2010) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2010.59.1.3 · Cited by 64
McDonald, A. J., & Mascagni, F. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20101 · Cited by 63
In vitro networks: cortical mechanisms of anaesthetic action
Antkowiak, B. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef154 · Cited by 63
Sullivan, S. K., Petroski, R. E., Verge, G. M., Gross, R. S., Foster, A. C., & Grigoriadis, D. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071282 · Cited by 63
Ali, A. B. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00156.2007 · Cited by 62
Varlinskaya, E. I., Doremus-Fitzwater, T. L., & Spear, L. P. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.011 · Cited by 54
Anesthetic-mediated protection/preconditioning during cerebral ischemia
Clarkson, A. N. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.022 · Cited by 62
Alteration of GABA ergic neurotransmission in Huntington's disease
Garret, M., Du, Z., Chazalon, M., Cho, Y. H., & Baufreton, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12826 · Cited by 62
Fradley, R. L., Guscott, M. R., Bull, S., Hallett, D. J., Goodacre, S. C., Wafford, K. A., Garrett, E. M., Newman, R. J., O’Meara, G. F., Whiting, P. J., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106067255 · Cited by 62
Molecular Targets of Anxiety: From Membrane to Nucleus
Wu, L., Kim, S. S., & Zhuo, M. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9679-8 · Cited by 61
Castellano, D., Shepard, R. D., & Lü, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.616298 · Cited by 61
Khom, S., Strommer, B., Ramharter, J., Schwarz, T., Schwarzer, C., Erker, T., Ecker, G. F., Mulzer, J., & Hering, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00865.x · Cited by 61
Naturally occurring 2′-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands
Huen, M. S. Y., Hui, K., Leung, J. W. C., Sigel, E., Baur, R., Wong, J. T.-F., & Xue, H. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.016 · Cited by 61
The Non-Benzodiazepine Hypnotic Zolpidem Impairs Sleep-Dependent Cortical Plasticity
(2008) · Sleep · doi:10.5665/sleep/31.10.1381 · Cited by 60
Blednov, Y. A., Borghese, C. M., McCracken, M. L., Benavidez, J. M., Geil, C., Osterndorff-Kahanek, E. A., Werner, D. F., Iyer, S. V., Swihart, A., Harrison, N. L., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171645 · Cited by 60
Vinkers, C. H., Klanker, M., Groenink, L., Korte, S. M., Cook, J. M., Linn, M. L. V., Hopkins, S. C., & Olivier, B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1460-4 · Cited by 60
Chen, X., van Gerven, J., Cohen, A. F., & Jacobs, G. E. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0185-5 · Cited by 60
The promise of new antiepileptic drugs
Duncan, J. S. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01540.x · Cited by 60
Follesa, P., Mancuso, L., Biggio, F., Cagetti, E., Franco, M., TRAPANI, G., & Biggio, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00167-8 · Cited by 60
Savić, M. M., Clayton, T., Furtmüller, R., Gavrilović, I., Samardžić, J., Savic, S. D., Huck, S., Sieghart, W., & Cook, J. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.020 · Cited by 60
Effects of benzodiazepines receptor agonists on the hypothalamic–pituitary–adrenocortical axis
Mikkelsen, J. D., Søderman, A., Kiss, A., & Mirza, N. R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.049 · Cited by 60
Alcohol effects on γ-aminobutyric acid type A receptors: are extrasynaptic receptors the answer?
Hanchar, H. J., Wallner, M., & Olsen, R. W. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.035 · Cited by 60
Carling, R. W., Madin, A., Guiblin, A., Russell, M. G. N., Moore, K. W., Mitchinson, A., Sohal, B., Pike, A., Cook, S. M., Ragan, I. C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058034a · Cited by 53
Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Decobert, M., Françon, D., Avenet, P., Depoortere, H., Tan, S., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29437-4 · Cited by 59
GABA A receptor modulation by neurosteroids in models of temporal lobe epilepsies
Ferando, I., & Módy, I. (2012) · Epilepsia · doi:10.1111/epi.12038 · Cited by 59
Karim, N., Curmi, J., Gavande, N. S., Johnston, G. A. R., Hanrahan, J. R., Tierney, M. L., & Chebib, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01604.x · Cited by 59
Lager, E., Andersson, P., Nilsson, J., Pettersson, I., Nielsen, E. Ø., Nielsen, M., Sterner, O., & Liljefors, T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm058057p · Cited by 59
Monoamines, GABA, Glutamate, and Aggression
Miczek, K. A., & Fish, E. W. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195168761.003.0005 · Cited by 59
Pistos, C. M., & Stewart, J. T. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00426-6 · Cited by 59
New molecular targets for antianxiety interventions.
Gorman, J. M. (2003) · PubMed · Cited by 59
Diazepam‐induced adaptive plasticity revealed by α1 GABAA receptor‐specific expression profiling
Huopaniemi, L., Keist, R., Randolph, A., Certa, U., & Rudolph, U. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02216.x · Cited by 58
“Wild-type and a1(H101R) male mice (Rudolph et al. 1999) were housed in groups of 10 under a 12-h light/dark cycle (light on from 06 : 30 h to 18 : 30 h), with food and water being provided ad libitum.”
BackgroundMethodSelf-citationInvolvement of the GABAergic system in PTSD and its therapeutic significance
Huang, J., Xu, F., Yang, L., Tuolihong, L., Wang, X., Du, Z., Zhang, Y., Yin, X., Li, Y., Lu, K., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1052288 · Cited by 59
Hagenbuch, N., Feldon, J., & Yee, B. K. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000189811.77049.3e · Cited by 58
Sonner, J. M., Cascio, M., Xing, Y., Fanselow, M. S., Kralic, J. E., Morrow, A. L., Korpi, E. R., Hardy, S. L., Sloat, B. R., Eger, E. I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009936 · Cited by 58
Follesa, P., Cagetti, E., Mancuso, L., Biggio, F., Manca, A., Maciocco, E., Massa, F., Desole, M. S., Carta, M., Busonero, F., et al. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00164-4 · Cited by 58
Genetic manipulations of GABAA receptor in mice make inhibition exciting
Vicini, S., & Ortinski, P. I. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.001 · Cited by 58
Behlke, L. M., Foster, R. A., Liu, J., Benke, D., Benham, R. S., Nathanson, A. J., Yee, B. K., Zeilhofer, H. U., Engin, E., & Rudolph, U. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.49 · Cited by 57
Self-citationVargas‐Caballero, M., Martin, L. J., Salter, M. W., Orser, B. A., & Paulsen, O. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.005 · Cited by 57
Himmel, H. M. (2008) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2008.06.001 · Cited by 57
Savić, M. M., Majumder, S., Huang, S., Edwankar, R. V., Furtmüller, R., Joksimovic, S. M., Clayton, T., Ramerstorfer, J., Milinković, M. M., Roth, B. L., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.004 · Cited by 57
Gourley, S. L., DeBold, J. F., Yin, W., Cook, J. M., & Miczek, K. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1987-3 · Cited by 57
GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies
Yanovsky, Y., Schubring, S. R., Fleischer, W., Gisselmann, G., Zhu, X., Lübbert, H., Hatt, H. H., Rudolph, U., Haas, H. L., & Sergeeva, O. A. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0988-4 · Cited by 56
Self-citationPrescription Drugs Used in Insomnia
Dujardin, S., Pijpers, A., & Pevernagie, D. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.002 · Cited by 56
Modulation of GABAA receptor gene expression by allopregnanolone and ethanol
Follesa, P., Biggio, F., Caria, S., Gorini, G., & Biggio, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.041 · Cited by 56
Liao, M. Y., Sonner, J. M., Jurd, R., Rudolph, U., Borghese, C. M., Harris, R. A., Laster, M. J., & Eger, E. I. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000154196.86587.35 · Cited by 56
Self-citationAnxiety-Related Mechanisms of Respiratory Dysfunction in a Mouse Model of Rett Syndrome
Ren, J., Ding, X., Funk, G. D., & Greer, J. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2951-12.2012 · Cited by 51
Terpenoid content of Valeriana wallichii extracts and antidepressant‐like response profiles
Subhan, F., Karim, N., Gilani, A. H., & Sewell, R. D. E. (2009) · Phytotherapy Research · doi:10.1002/ptr.2980 · Cited by 56
Stefanits, H., Milenković, I., Mahr, N., Pataraia, E., Hainfellner, J. A., Kovács, G. G., Sieghart, W., Yilmazer‐Hanke, D., & Czech, T. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24337 · Cited by 56
Acquired Carnitine Deficiency: A Clinical Model for Propofol Infusion Syndrome?
Uezono, S., Hotta, Y., Takakuwa, Y., & Ozaki, M. (2005) · Anesthesiology · doi:10.1097/00000542-200510000-00046 · Cited by 56
Anxiolytic-like action of diazepam: which GABAA receptor subtype is involved?
Reynolds, D. S., McKernan, R. M., & Dawson, G. R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01773-9 · Cited by 56
Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Munro, G., Erichsen, H. K., Rae, M. G., & Mirza, N. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.017 · Cited by 55
Jacobson‐Pick, S., & Richter‐Levin, G. (2011) · Stress · doi:10.3109/10253890.2011.634036 · Cited by 55
Gibson, C. J., Meyer, R. C., & Hamm, R. J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-38 · Cited by 55
Microcystin-LR induces changes in the GABA neurotransmitter system of zebrafish
Yan, W., Li, L., Li, G., & Zhao, S. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.05.006 · Cited by 55
Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications
Cai, H., Cao, T., Zhou, X., & Yao, J. K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00073 · Cited by 55
Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone
Pinna, G. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00114 · Cited by 55
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.